NEW ORLEANS, Nov. 12, 2016 - A new training model improved CPR skills in a clinical setting according to research presented during the Resuscitation Science Symposium at the American Heart Association's Scientific Sessions 2016.
Currently, hospital staff are only required to undergo formal CPR training every two years. This study examined whether CPR proficiency within a hospital setting could be improved with low dose-high frequency psychomotor simulation among hospitals using the American Heart Association's Resuscitation Quality Improvement™ (RQI) mobile simulation stations.
"High-quality CPR is essential for functional survival from cardiac arrest," said lead study author Michael C. Kurz, M.D., M.S., an associate professor in the Department of Emergency Medicine at the University of Alabama at Birmingham. "However, the opportunity to perform CPR is too infrequent currently to maintain proficiency for most providers."
In the study, two mobile simulation stations were placed in the emergency department of the University of Alabama at Birmingham Hospitals. Quarterly training simulations were integrated into the normal duties of 150 emergency department nurses beginning in June 2015.
When compared to baseline data, use of mobile simulation stations for one year was associated with improved simulated chest compression fraction as well as percentage of compressions with both adequate recoil and depth.
"Furthermore, clinical data collected before and after RQI implementation demonstrated a 14 percent improvement in chest compression fraction delivered to cardiac arrest victims in the Emergency Department," Kurz said.
The study was partially funded by the American Heart Association.
Note: Scientific presentation time is 8:48 a.m. CT, Sunday, Nov. 13, in Great Hall D.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.